766 related articles for article (PubMed ID: 24177375)
1. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
[TBL] [Abstract][Full Text] [Related]
2. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
Rutgeerts P; Diamond RH; Bala M; Olson A; Lichtenstein GR; Bao W; Patel K; Wolf DC; Safdi M; Colombel JF; Lashner B; Hanauer SB
Gastrointest Endosc; 2006 Mar; 63(3):433-42; quiz 464. PubMed ID: 16500392
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.
Rimola J; Rodriguez S; García-Bosch O; Ordás I; Ayala E; Aceituno M; Pellisé M; Ayuso C; Ricart E; Donoso L; Panés J
Gut; 2009 Aug; 58(8):1113-20. PubMed ID: 19136510
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic and histologic evidence of persistent mucosal healing and correlation with clinical improvement following sustained infliximab treatment for Crohn's disease.
Geboes K; Rutgeerts P; Opdenakker G; Olson A; Patel K; Wagner CL; Marano CW
Curr Med Res Opin; 2005 Nov; 21(11):1741-54. PubMed ID: 16307694
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance Index of Activity (MaRIA) is reliable in assessing response to treatment in patients with Crohn's disease (CD).
Zhang YN; Liu YB; Xu J; Cao KM; Zhang XX; Wang YB; Liu F; Duan BS; Hu YD; Chu SG
Clin Radiol; 2024 Mar; 79(3):230-236. PubMed ID: 38092646
[TBL] [Abstract][Full Text] [Related]
6. Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn's Disease.
Zittan E; Kabakchiev B; Milgrom R; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
J Crohns Colitis; 2016 May; 10(5):510-5. PubMed ID: 26783345
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P
Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
[TBL] [Abstract][Full Text] [Related]
8. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the magnetic resonance scoring systems for Crohn's disease activity: MaRIA, simplified MaRIA, and Nancy scores.
Lee WE; Weng MT; Wei SC; Shih IL
Abdom Radiol (NY); 2023 Jul; 48(7):2228-2236. PubMed ID: 37129624
[TBL] [Abstract][Full Text] [Related]
10. Defining Magnetic Resonance Imaging Treatment Response and Remission in Crohn's Disease: A Systematic Review.
Caron B; Jairath V; Laurent V; Stoker J; Laghi A; D'Haens GR; Danese S; Peyrin-Biroulet L
J Crohns Colitis; 2024 Jan; 18(1):162-170. PubMed ID: 37523157
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas.
Ng SC; Plamondon S; Gupta A; Burling D; Swatton A; Vaizey CJ; Kamm MA
Am J Gastroenterol; 2009 Dec; 104(12):2973-86. PubMed ID: 19755971
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.
Colombel JF; Sandborn WJ; Rutgeerts P; Kamm MA; Yu AP; Wu EQ; Pollack PF; Lomax KG; Chao J; Mulani PM
Am J Gastroenterol; 2009 May; 104(5):1170-9. PubMed ID: 19352339
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT.
Louis E; Ancion G; Colard A; Spote V; Belaiche J; Hustinx R
J Nucl Med; 2007 Jul; 48(7):1053-9. PubMed ID: 17574978
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting.
Trinder MW; Lawrance IC
J Gastroenterol Hepatol; 2009 Jul; 24(7):1252-7. PubMed ID: 19220669
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.
D'haens G; Van Deventer S; Van Hogezand R; Chalmers D; Kothe C; Baert F; Braakman T; Schaible T; Geboes K; Rutgeerts P
Gastroenterology; 1999 May; 116(5):1029-34. PubMed ID: 10220494
[TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy with certolizumab pegol for Crohn's disease.
Schreiber S; Khaliq-Kareemi M; Lawrance IC; Thomsen OØ; Hanauer SB; McColm J; Bloomfield R; Sandborn WJ;
N Engl J Med; 2007 Jul; 357(3):239-50. PubMed ID: 17634459
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic scoring indices for evaluation of disease activity in Crohn's disease.
Khanna R; Nelson SA; Feagan BG; D'Haens G; Sandborn WJ; Zou GY; MacDonald JK; Parker CE; Jairath V; Levesque BG
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010642. PubMed ID: 27501379
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease.
Sipponen T; Savilahti E; Kärkkäinen P; Kolho KL; Nuutinen H; Turunen U; Färkkilä M
Inflamm Bowel Dis; 2008 Oct; 14(10):1392-8. PubMed ID: 18484671
[TBL] [Abstract][Full Text] [Related]
19. Certolizumab pegol for the management of Crohn's disease in adults.
Rivkin A
Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of evaluating Crohn's disease activity at 3.0 Tesla.
van Gemert-Horsthuis K; Florie J; Hommes DW; Lavini C; Reitsma JB; van Deventer SJ; Stoker J
J Magn Reson Imaging; 2006 Aug; 24(2):340-8. PubMed ID: 16786589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
